Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/1/23 → 1/31/26 |
A Phase II,Randomized, Observer-blinded, Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women between Gestational Age 14-34 weeks and Non-Pregnant Women of 16-45 years old."
- Kmush, Brittany (PI)
Project: Sponsored Project